Shao Hui, Kaplan Henry J, Sun Deming
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, Louisville, KY, United States.
Department of Ophthalmology, Saint Louis University School of Medicine, Saint Louis, MO, United States.
Front Ophthalmol (Lausanne). 2022;2. doi: 10.3389/fopht.2022.831084. Epub 2022 Mar 7.
Pro- and ant-inflammatory effects of IFN-γ have been repeatedly found in various immune responses, including cancer and autoimmune diseases. In a previous study we showed that the timing of treatment determines the effect of adenosine-based immunotherapy. In this study we examined the role of IFN-γ in pathogenic Th17 responses in experimental autoimmune uveitis (EAU). We observed that IFN-γ has a bidirectional effect on Th17 responses, when tested both and . Anti-IFN-γ antibody inhibits Th17 responses when applied in the initial phase of the immune response; however, it enhances the Th17 response if administered in a later phase of EAU. In the current study we showed that IFN-γ is an important immunomodulatory molecule in γδ T cell activation, as well as in Th17 responses. These results should advance our understanding of the regulation of Th17 responses in autoimmunity.
IFN-γ的促炎和抗炎作用在包括癌症和自身免疫性疾病在内的各种免疫反应中反复被发现。在先前的一项研究中,我们表明治疗时机决定了基于腺苷的免疫疗法的效果。在本研究中,我们研究了IFN-γ在实验性自身免疫性葡萄膜炎(EAU)致病性Th17反应中的作用。我们观察到,当在[此处原文缺失相关测试条件]进行测试时,IFN-γ对Th17反应具有双向作用。抗IFN-γ抗体在免疫反应初始阶段应用时会抑制Th17反应;然而,如果在EAU后期给药,则会增强Th17反应。在当前研究中,我们表明IFN-γ是γδT细胞活化以及Th17反应中的重要免疫调节分子。这些结果应能增进我们对自身免疫中Th17反应调节的理解。